Physician profile
Gregory M Ford
NPI 1104928670
$23,318.17
in general payments reported to CMS, 2019-2025
13 companies · $1,760 in 2025
The $1,760 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $254 · 2021: $1,539 · 2022: $355 · 2023: $5,925 · 2024: $1,565 · 2025: $1,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,600 · Travel and Lodging: $2,037 · Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,600.00 |
| Travel and Lodging | $2,037.19 |
| Food and Beverage | $1,612.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $20,528.99 | 2019-2025 | Gmk Sphere, Gmk Revision, Mecta |
| Active Medical, LLC | $799.48 | 2023-2025 | |
| Stryker Corporation | $726.90 | 2019-2025 | Aequalis Perform+, Aequalis Perform Reversed |
| Arthrex, INC. | $673.29 | 2025 | |
| Depuy Synthes Sales INC. | $112.50 | 2019-2023 | Orthovisc, Monovisc, Peak |
| Paragon 28, INC. | $102.00 | 2025 | Avitus Bone Graft Harvester |
| Heron Therapeutics, INC. | $97.02 | 2021-2023 | Zynrelef |
| Vericel Corporation | $88.12 | 2020-2023 | Maci |
| Smith+Nephew, INC. | $76.26 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $31.92 | 2019 | |
| Ethicon US, LLC | $31.49 | 2021 | |
| Boston Scientific Corporation | $31.13 | 2024-2025 | Intracept |
| Pacira Pharmaceuticals Incorporated | $19.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.